A drug development in cardiovascular disease is getting more specific and focused. This requires adept scientific and operational expertise. We are guided by a team of experts that helps us attain specific requirements of robust development, meticulous conduct and classical understanding of data to drive the clinical development of molecule.
With over a decade of exposure in clinical operations we have network of more than 100 sites for your clinical development program. Founded by a team of cardiologist, Vibgyor presents a major advantage of exceptional understanding of the nuances in cardiovascular segment.